BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15379351)

  • 1. Ozone therapy and pressure-pulse therapy in Ménière's disease.
    Pawlak-Osińska K; Kaźmierczak H; Kaźmierczak W; Szpoper M
    Int Tinnitus J; 2004; 10(1):54-7. PubMed ID: 15379351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternobaric oxygen therapy in long-term treatment of Ménière's disease.
    Fattori B; De Iaco G; Nacci A; Casani A; Ursino F
    Undersea Hyperb Med; 2002; 29(4):260-70. PubMed ID: 12797667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate effects of middle ear pressure changes on the electrocochleographic recordings in patients with Menière's disease: a clinical placebo-controlled study.
    Densert B; Densert O; Arlinger S; Sass K; Odkvist L
    Am J Otol; 1997 Nov; 18(6):726-33. PubMed ID: 9391668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in input/output function of distortion product otoacoustic emissions during the glycerol test in Ménière's disease.
    Sakashita T; Shibata T; Yamane H; Hikawa C
    Acta Otolaryngol Suppl; 2004 Oct; (554):26-9. PubMed ID: 15513506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Distortion product otoacoustic emissions in Ménière's disease].
    Pérez N; Manrique M; García-Tapia R
    Acta Otorrinolaringol Esp; 1995; 46(1):1-6. PubMed ID: 7734155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Objective evaluation of the effects of intravenous lidocaine on tinnitus.
    Kalcioglu MT; Bayindir T; Erdem T; Ozturan O
    Hear Res; 2005 Jan; 199(1-2):81-8. PubMed ID: 15574302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of perilymphatic pressure using the MMS-10 tympanic membrane displacement analyzer (Marchbanks' test) in patients with Meniere's disease: preliminary report].
    Ayache D; Nengsu Tchuente A; Plouin-Gaudon I; Vasseur J; Elbaz P
    Ann Otolaryngol Chir Cervicofac; 2000 Jun; 117(3):183-8. PubMed ID: 10863204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
    Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of the vestibular evoked myogenic potential test in assessing intratympanic gentamicin therapy in Meniere's disease.
    Ozluoglu LN; Akkuzu G; Ozgirgin N; Tarhan E
    Acta Otolaryngol; 2008 Apr; 128(4):422-6. PubMed ID: 18368577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ménière's syndrome.
    Wright A
    Br J Hosp Med; 1985 Dec; 34(6):366-70. PubMed ID: 4084707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transtympanic gentamicin treatment in Meniere's disease: a preliminary report.
    Kasemsuwan L; Jariengprasert C; Chaturapatranont S
    J Med Assoc Thai; 2006 Jul; 89(7):979-85. PubMed ID: 16881430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratympanic application of an antiviral agent for the treatment of Ménière's disease.
    Guyot JP; Maire R; Delaspre O
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(1):21-6; discussion 26-7. PubMed ID: 18235202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of tone burst vestibular evoked myogenic potentials at threshold in acute and stable Ménière's disease.
    Osei-Lah V; Ceranic B; Luxon LM
    J Laryngol Otol; 2008 May; 122(5):452-7. PubMed ID: 17605832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vestibular evoked myogenic potentials in acute low-tone sensorineural hearing loss.
    Wu CL; Young YH
    Laryngoscope; 2004 Dec; 114(12):2172-5. PubMed ID: 15564839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evoked otoacoustic emission in conduction of dehydration tests in patients with Meniere's disease].
    Levina IuV
    Vestn Otorinolaringol; 2004; (4):11-4. PubMed ID: 15496832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating the cause of acute sensorineural hearing loss between Ménière's disease and sudden deafness.
    Chen CN; Young YH
    Acta Otolaryngol; 2006 Jan; 126(1):25-31. PubMed ID: 16308251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.
    Helling K; Schönfeld U; Clarke AH
    Laryngoscope; 2007 Dec; 117(12):2244-50. PubMed ID: 17909448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of glycerol intake and body tilt on otoacoustic emissions reflect labyrinthine pressure changes in Menière's disease.
    Mom T; Gilain L; Avan P
    Hear Res; 2009 Apr; 250(1-2):38-45. PubMed ID: 19450433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose transtympanic gentamicin treatment for intractable Meniere's disease: a prospective study.
    Kasemsuwan L; Jariengprasert C; Ruencharopen S; Orathai P
    J Med Assoc Thai; 2007 Feb; 90(2):327-34. PubMed ID: 17375639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.